IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,905,679 | +15.8% | 549,067 | +4.8% | 0.18% | +14.2% |
| Q2 2023 | $21,502,469 | +46.8% | 524,067 | +17.7% | 0.16% | +52.0% |
| Q1 2023 | $14,645,258 | -16.7% | 445,197 | -4.4% | 0.10% | -14.3% |
| Q4 2022 | $17,588,665 | -11.9% | 465,700 | +3.2% | 0.12% | -15.6% |
| Q3 2022 | $19,964,000 | -5.5% | 451,351 | -20.9% | 0.14% | -19.0% |
| Q2 2022 | $21,126,000 | +14.2% | 570,692 | +14.2% | 0.17% | +38.1% |
| Q1 2022 | $18,502,000 | -35.1% | 499,547 | -46.7% | 0.13% | -30.8% |
| Q4 2021 | $28,502,000 | +17.0% | 936,635 | +28.9% | 0.18% | +9.6% |
| Q3 2021 | $24,361,000 | +10.5% | 726,359 | +31.5% | 0.17% | +9.9% |
| Q2 2021 | $22,042,000 | +64.3% | 552,566 | +123.8% | 0.15% | +34.8% |
| Q1 2021 | $13,412,000 | -3.9% | 246,954 | 0.0% | 0.11% | +1.8% |
| Q4 2020 | $13,963,000 | +16.0% | 246,954 | -2.7% | 0.11% | -2.7% |
| Q3 2020 | $12,038,000 | -19.5% | 253,700 | 0.0% | 0.11% | -28.5% |
| Q2 2020 | $14,959,000 | -3.2% | 253,700 | -3.1% | 0.16% | -7.6% |
| Q1 2020 | $15,454,000 | -2.2% | 261,700 | 0.0% | 0.17% | +1.2% |
| Q4 2019 | $15,809,000 | -10.0% | 261,700 | -10.7% | 0.17% | -27.5% |
| Q3 2019 | $17,566,000 | -6.4% | 293,200 | 0.0% | 0.23% | -0.4% |
| Q2 2019 | $18,761,000 | -41.2% | 293,200 | -25.4% | 0.23% | -42.6% |
| Q1 2019 | $31,917,000 | +136.9% | 393,200 | +57.8% | 0.41% | +97.1% |
| Q4 2018 | $13,471,000 | +30.5% | 249,200 | +24.5% | 0.21% | +51.1% |
| Q3 2018 | $10,326,000 | +59.1% | 200,200 | +28.5% | 0.14% | +33.0% |
| Q2 2018 | $6,492,000 | +3.7% | 155,800 | +9.7% | 0.10% | -3.7% |
| Q1 2018 | $6,260,000 | -12.4% | 142,000 | 0.0% | 0.11% | -13.7% |
| Q4 2017 | $7,143,000 | -1.5% | 142,000 | -0.7% | 0.12% | -2.4% |
| Q3 2017 | $7,250,000 | +29.6% | 143,000 | +30.0% | 0.13% | +21.0% |
| Q2 2017 | $5,596,000 | -27.1% | 110,000 | -42.4% | 0.10% | -29.5% |
| Q1 2017 | $7,679,000 | +8.5% | 191,000 | +29.1% | 0.15% | -8.0% |
| Q4 2016 | $7,079,000 | +114.6% | 148,000 | +64.4% | 0.16% | +105.1% |
| Q3 2016 | $3,298,000 | -28.8% | 90,000 | -21.7% | 0.08% | -31.9% |
| Q1 2016 | $4,630,000 | -25.6% | 114,939 | +14.4% | 0.12% | -30.1% |
| Q4 2015 | $6,223,000 | – | 100,485 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |